psalexa
P&S Market Research - A market research firm

Androgenic Alopecia Therapeutics Pipeline Analysis

Androgenic Alopecia Therapeutics Pipeline Analysis 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

Delivery : 1-2 Working Days
Report Code: LS11169
Available Format:

Androgenic Alopecia is a genetic disorder characterized by the hair loss in both men and women. The disease occurs when terminal hair is gradually converted into indeterminate, and finally into vellus, hair. The predisposing factors for androgenic alopecia include allergies, burns, irritants, injuries, infections and toxins. Androgenetic alopecia in men has been associated with several other medical conditions including enlargement of the prostate and coronary heart diseases. In women, this form of hair loss is associated with an increased risk of polycystic ovary syndrome. The deficiency of 5-alpha reductase, an enzyme that regulates production of DHT, causes androgenic alopecia.

The drug candidates of androgenic alopecia pipeline include, but are not limited to, DA-4001, SM 04554 and Finasteride. Some of the companies having drugs in the pipeline for androgenic alopecia include Aclaris Therapeutics Inc., Almirall SA, Histogen Inc. and Samumed LLC.

The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with detailed analysis of pipeline and clinical trials. Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licencing, grants, technology and others.

Place An Order

Single User License
question-mark

The report will be delivered in PDF format without printing rights. It is recommended for a single user.

USD 3250
Group License
question-mark

The report will be delivered in PDF format along with the printing rights. It is recommended for up to five users.

USD 4000
Enterprise License
question-mark

The report will be delivered in PDF format along with printing rights and detailed Excel sheet. It is recommended for organizations where multiple people would like to access the report from multiple locations.

USD 7750

Pre-Purchase Enquiry